bioRxivPharmacology & ToxicologyPreprint
The Effect of a Fennel Extract on the STAT Signaling and Intestinal Barrier Function
J. Rabalais, P. Kozan, T. Lu, N. Durali, K. Okamoto, B. Das, M. D. McGeough, J. B. Lee, K. E. Barrett, R. Marchelletta, M. Sivagnanam
Abstract
BackgroundFoeniculum vulgare, F. vulgare, commonly known as fennel, is believed to be one of the worlds oldest medicinal herbs and has been exploited by people for centuries as a nutritional aid for digestive disorders. In many southeast Asian countries it is ingested as an after-meal snack, mukhvas, due to its breath-freshening and digestive aid properties. F. vulgare is used in some countries, such as Iran, as a complementary and alternative treatment for inflammatory bowel disease (IBD). MethodsThis study investigated the effects of F. vulgare on the barrier function of the intestinal epithelium Signal Transducer and Activator of Transcription (STAT) pathway, which is active in inflammatory bowel disease. To study the protective effects of F. vulgare extract in vitro, monolayers derived from the T84 colonic cell line were challenged with interferon-gamma (IFN-{gamma}) and monitored with and without F. vulgare extract. To complement our in vitro studies, the dextran sodium sulfate induced murine colitis model was employed to ascertain whether the protective effect of F. vulgare extract can be recapitulated in vivo. ResultsF. vulgare extract was shown to exert a protective effect on TEER in both T84 and murine models and showed increases in tight junction-associated mRNA in T84 cell monolayers. Both models demonstrated significant decreases in phosphorylated STAT1 (pSTAT1), indicating reduced activation of the STAT pathway. Additionally, mice treated with F. vulgare showed significantly lower ulcer indices than control mice. ConclusionsWe conclude barrier function of the gastrointestinal tract is improved by F. vulgare, suggesting the potential utility of this agent as an alternative or adjunctive therapy in IBD.
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discordant effects of ex-vivo JAK inhibition on inflammatory responses in colonic compared to ileal mucosa
K. Kaboub, H. Abu-Taha, … K. M. Rabinowitz·bioRxiv·Jan 18, 2024
- Impact of a standardized Tetradesmus obliquus Mi175.B1.a extract on gut function and physiology in inflammatory conditions: in vitro and in vivo insights
Jonathan Maury, Pierre Albina, … Rémi Pradelles·bioRxiv·May 21, 2025
- Reduction of fungal dysbiosis is involved in the attenuation of Dextran Sodium Sulfate-Induced Mouse Colitis Mediated by GILZ protein and yeast extract compound
Marco Gentili, Emilia Nunzi, … Claudia Monari·BiomoleculesPeer-reviewed·Oct 17, 2024
- Optogenetic inhibition of colon epithelium reduces hypersensitivity in a mouse model of inflammatory bowel disease
Sarah A. Najjar, Lindsay L. Ejoh, … Kathryn M. Albers·PainPeer-reviewed·Oct 12, 2020
- Type I interferon signaling promotes mucosal inflammation in murine models of colitis
Jianyi Yin, Rodrigo Galicia-Pereyra, … Ezra Burstein·bioRxiv·Mar 4, 2026
- Plant Molecules Protect Against Inflammatory Bowel Disease by Restoring Gut Microbiota-Immune Homeostasis and Suppressing Pro-inflammatory Markers
Karma Yeshi, Subir Sarker, … Phurpa Wangchuk·bioRxiv·Aug 25, 2026